FREE PASS
Please note that this free pass is limited to active researchers from pharmaceutical companies, biotech organisations, research centres, academic institutes and CROs
Applications will only be accepted with a company email address
As advancements in cell and gene therapies continue to accelerate and reach the clinic, the spotlight is now focused on improving safety, efficacy and scale-up at the pre-clinical stage.
Drug Target Review’s new virtual summit explored the latest developments in cell and gene therapies. In this two-day online conference, gain access to the latest research from leading scientists and experts.
Speakers from global pharmaceutical companies, biotech organizations, CROs and academic institutes presented the latest innovations in the application of cell and gene therapies across a range of indications and how researchers can work towards delivering innovative treatments to patients.
Please note that the free pass is limited to active researchers from pharmaceutical companies, biotech organisations, research centres, academic institutes and CROs.
All sessions are now available to watch on-demand.
Over 600 scientists, researchers and experts from across the globe from pharmaceutical companies, biotech organizations, CROs and academic institutes focused on driving innovation across cell & gene therapy advancements.
If you are part of a pharmaceutical company, biotech organizations, CRO or an academic institutes you can attend this online summit for FREE. Apply for your free pass today.
All other attendees can take advantage of our early bird discounts and make sure you don’t miss out accessing the latest research in immuno-oncology, genome editing, stem cell therapies and personalized medicine.
Considering the growing number benefits that cell and gene therapies have provided when treating a wide range of conditions, researchers around the world have turned their attention to this next-generation class of biologics. From lower dosages to longer-lasting effects, the advantages of these therapies mean that scientists are working to accelerate them towards the clinic. In the original pieces listed below, experts in this whitepaper discuss the most recent progress in cell and gene therapies, from immuno-oncology to gene therapy for ocular conditions to stem cells.
Included in this whitepaper:
Cell & Gene Therapy Advancements Online Summit was held
live in November and is now available to watch on-demand. All session can be
watch on-demand for 12 months. Valid until 4 Nov 2022.
Please note that this free pass is limited to active researchers from pharmaceutical companies, biotech organisations, research centres, academic institutes and CROs
Applications will only be accepted with a company email address
Cell & Gene Therapy Advancements Online Summit was held
live in November and is now available to watch on-demand. All session can be
watch on-demand for 12 months. Valid until 4 Nov 2022.
Access speaking opportunities to position your brand as a thought leader, generate qualified leads, create brand awareness and receive detailed analytics. We commit to providing you full onboarding and support, as well as helping you deliver ROI.
Cookie | Description |
---|---|
cookielawinfo-checkbox-analytics | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-non-necessary | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Non Necessary". |
cookielawinfo-checkbox-others | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
PHPSESSID | This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed. |
viewed_cookie_policy | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Description |
---|---|
_stripe_mid | This cookie is set by the payment processor Stripe. It is used to assist with user identification and fraud prevention during the processing of payments. |
_stripe_sid | This cookie is set by the payment processor Stripe. It stores a unique session ID for the purpose of managing the user session during the checkout process. The cookie is a session cookies and is deleted when all the browser windows are closed. |
AWSALB | AWSALB is a cookie generated by the Application load balancer in the Amazon Web Services. It works slightly different from AWSELB. |
AWSALBCORS | AWSALB is a cookie generated by the Application load balancer in the Amazon Web Services. |
ls_smartpush | This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site. |
one_signal_sdk_db | This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status. |
Cookie | Description |
---|---|
_ga | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
_gat_gtag_UA_10556842_35 | Google uses this cookie to distinguish users. |
_gat_tt | This cookie is installed by Google Analytics. The cookie is used to throttle the request rate. |
_gid | This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form. |
wow.anonymousId | This cookie from Communigator tracks an anonymous visitor ID. |
wow.schedule | This standard session cookie served by the web server enables Communigator to track the Load Balance Session Queue. |
wow.session | This standard session cookie served by the web server enables Communigator to track the Internet Information Services (IIS) session state. |
wow.utmvalues | This cookie from Communigator stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on. |
zform_campaign_source | This cookie records the marketing campaign source if it exists as a parameter e.g. zcs=campaign_source. |
Cookie | Description |
---|---|
NID | This cookie is used to a profile based on user's interest and display personalized ads to the users. |